FFA
ADPT icon

Farther Finance Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Farther Finance Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.22K Buy
146
+80
+121% +$1.97K ﹤0.01% 5106
2026
Q2 		$1.42K Sell
66
-101
-60% -$1.55K ﹤0.01% 5272
2026
Q1 		$2.41K Sell
167
-272
-62% -$4.33K ﹤0.01% 4830
2025
Q4 		$7.13K Buy
439
+380
+644% +$6.2K ﹤0.01% 4121
2025
Q3 		$883 Buy
59
+30
+103% +$366 ﹤0.01% 4402
2025
Q2 		$338 Buy
29
+6
+26% +$54 ﹤0.01% 4119
2025
Q1 		$173 Hold
23
– – ﹤0.01% 3976
2024
Q4 		$138 Hold
23
– – ﹤0.01% 3728
2024
Q3 		$118 Sell
23
-25
-52% -$109 ﹤0.01% 3751
2024
Q2 		$173 Buy
48
+23
+92% +$73 ﹤0.01% 3517
2024
Q1 		$78 Sell
25
-103
-80% -$399 ﹤0.01% 3415
2023
Q4 		$627 Buy
+128
New +$584 ﹤0.01% 2898
2023
Q3 		– Sell
-51
Closed -$342 – 2617
2023
Q2 		$342 Hold
51
– – ﹤0.01% 2252
2023
Q1 		$450 Hold
51
– – ﹤0.01% 2030
2022
Q4 		$390 Buy
+51
New +$397 ﹤0.01% 1880

Other funds holding ADPT

WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's ADPT Position: Q3 2026 in Review

Farther Finance Advisors increased its Adaptive Biotechnologies (ADPT) stake by 121% in Q3 2026, buying an estimated $1.97K and bringing the position to 146 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #5106.

Farther Finance Advisors first reported a position in ADPT in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.13K in Q4 2025. 8 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Farther Finance Advisors held 146 shares of Adaptive Biotechnologies worth $4.22K as of Q3 2026.
  • Farther Finance Advisors bought 80 Adaptive Biotechnologies shares in Q3 2026, an estimated $1.97K.
  • Adaptive Biotechnologies made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5106 holding.
  • Farther Finance Advisors first reported a position in Adaptive Biotechnologies in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Adaptive Biotechnologies position peaked at $7.13K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.